Concepedia
Statistics
Publications
11
Citations
1.1K
H-Index
10
Active since
1979
Affiliations
Burroughs Wellcome Fund(Current)
Environmental Protection Agency
Massachusetts General Hospital
Research Triangle Park Foundation
Florida Institute of Technology
A. G. Batson is an author at Burroughs Wellcome Fund specializing in medicine, pharmacology, and clinical pharmacology.
Publications per year
1979–1989
Validation and characterization of the L5178Y/TK+/- mouse lymphoma mutagen assay system
D. Clive, K. Johnson, J.F.S. Spector et al. · Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis · 1979 · 566 citations
Veterinary Medicine, Cancer Biology, Oncology +5
Analysis of trifluorothymidine-resistant (TFTr) mutants of L5178Y/TK+/− mouse lymphoma cells
Martha M. Moore, D. Clive, John Hozier et al. · Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis · 1985 · 156 citations
Medicine, Molecular Biology, Oncology +5
ATRACURIUM: CLINICAL STRATEGIES FOR PREVENTING HISTAMINE RELEASE AND ATTENUATING THE HAEMODYNAMIC RESPONSE
R.P.F. Scott, John J. Savarese, S. J. Basta et al. · British Journal of Anaesthesia · 1985 · 110 citations · Full text
Medicine, Anesthesiology, Pharmacology +10
In situ analysis of trifluorothymidine-resistant (TFTr) mutants of L5178Y/TK+/− mouse lymphoma cells
Martha M. Moore, D. Clive, Barry E. Howard et al. · Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis · 1985 · 80 citations
Trifenagrel: a chemically novel platelet aggregation inhibitor.
Sanders L. Abrahams, Richard Hazen, A. G. Batson et al. · Journal of Pharmacology and Experimental Therapeutics · 1989 · 57 citations
Medicine, Medicinal Chemistry, Pharmacology +15
1–5 of 11